Anxiety, Obsessive-Compulsive, and Related Disorders

Anxiety Disorders

  • Fear: Emotional response to a serious threat.

  • Anxiety: Response to vague sense of threat.

Generalized Anxiety Disorder (GAD)

  • Definition: Persistent and excessive worry about numerous events.

  • Prevalence: Most common mental disorder; 19% of U.S. adults annually.

  • Symptoms: Excessive anxiety lasting at least 6 months; must experience at least three symptoms (e.g., fatigue, irritability).

  • Sociocultural factors: GAD likely in high-stress environments.

  • Demographics: Affects 2:1 ratio of women to men.

Phobias

  • Definition: Intense, persistent fear; avoidance behavior; significant impairment in functioning.

  • Types: Specific phobias and agoraphobia.

  • Prevalence: 9% for specific phobias yearly; 1% for agoraphobia.

Social Anxiety Disorder

  • Symptoms: Disproportionate fear of social situations; usually begins in childhood/adolescence.

  • Prevalence: 7% yearly; 40% seek treatment.

Panic Disorder

  • Characteristics: Recurrent panic attacks; physical symptoms include heart palpitations & dizziness.

  • Prevalence: Affects 3.1% of U.S. annually; often begins in adolescence/adulthood.

Obsessive-Compulsive Disorder (OCD)

  • Obsessions: Intrusive thoughts leading to anxiety.

  • Compulsions: Repetitive behaviors aimed at reducing anxiety.

  • Prevalence: Affects 1% of the population; individuals often recognize irrationality of thoughts/behaviors.

Treatment Perspectives

  • Cognitive-Behavioral Therapy: Commonly effective for anxiety disorders, focusing on changing thought patterns.

  • Medication: Includes antidepressants and benzodiazepines.

  • Psychodynamic therapy: Explores underlying emotional issues.

  • Biological perspective: Focus on genetics and brain circuits associated with disorders.

Developmental Psychopathology Perspective

  • Explores interplay of biological, cognitive-behavioral, and emotional factors throughout life.


  • Fear: An emotional response triggered by a perceived serious threat, often characterized by heightened vigilance and physiological responses such as increased heart rate and sweating.

  • Anxiety: A psychological state characterized by a response to a vague sense of impending danger or threat, often leading to nervousness or apprehension, typically accompanied by physical symptoms such as muscle tension and restlessness.

Generalized Anxiety Disorder (GAD)

  • Definition: A mental health condition marked by persistent and excessive worry about a variety of events and aspects of life, often without a clear reason for the anxiety.

  • Prevalence: GAD is recognized as one of the most common mental disorders affecting adults, with an annual prevalence rate of approximately 19% among U.S. adults, highlighting the widespread nature of this disorder.

  • Symptoms: Individuals typically endure excessive anxiety lasting at least six months and must experience at least three specific symptoms, including but not limited to fatigue, irritability, difficulty concentrating, muscle tension, and sleep disturbances.

  • Sociocultural factors: The likelihood of developing GAD is higher in individuals living in high-stress environments, suggesting that societal pressures and economic factors can play a critical role in the onset of anxiety disorders.

  • Demographics: Statistically, GAD affects women twice as often as men, indicating potential gender differences in vulnerability to anxiety disorders.

Phobias

  • Definition: A phobia is characterized by an intense, persistent fear of a specific object, situation, or activity that results in strong avoidance behavior and can lead to significant impairment in daily functioning.

  • Types: Phobias are broadly categorized into specific phobias, which are fear responses to particular stimuli (such as heights or spiders), and agoraphobia, which involves fear of being in situations where escape might be difficult or help available might not be accessible.

  • Prevalence: Approximately 9% of the population experiences specific phobias annually, while agoraphobia affects around 1% of individuals each year, underscoring the varied landscape of anxiety disorders.

Social Anxiety Disorder

  • Symptoms: Individuals with social anxiety disorder experience an overwhelming and disproportionate fear of social situations, often fearing judgment or embarrassment, which commonly begins during childhood or adolescence.

  • Prevalence: Social anxiety affects approximately 7% of the U.S. population annually, with about 40% of those affected seeking professional treatment to manage their symptoms.

Panic Disorder

  • Characteristics: Panic disorder is characterized by recurrent and unexpected panic attacks, which are sudden surges of intense fear or discomfort that trigger severe physical symptoms such as heart palpitations, dizziness, shortness of breath, and feelings of impending doom.

  • Prevalence: The disorder impacts about 3.1% of the U.S. adult population each year, with symptoms that often manifest in adolescence or young adulthood, highlighting the critical age of onset and health impacts.

Obsessive-Compulsive Disorder (OCD)

  • Obsessions: These are persistent, intrusive thoughts or urges that lead to significant anxiety or distress. Common obsessions may include fears of contamination, harm, or a need for things to be organized in a particular manner.

  • Compulsions: In response to these obsessions, individuals engage in compulsive behaviors—repetitive actions or mental acts performed to reduce anxiety or prevent a feared event, such as excessive cleaning or checking behaviors.

  • Prevalence: OCD affects approximately 1% of the population, with many individuals recognizing the irrational nature of their obsessions and compulsive behaviors, which can lead to further distress and impairment in daily functioning.

Treatment Perspectives

  • Cognitive-Behavioral Therapy (CBT): This is a widely practiced therapeutic approach considered effective for treating anxiety disorders by focusing on the modification of negative thought patterns and behaviors.

  • Medication: Common pharmacological treatments for anxiety disorders include antidepressant medications (such as SSRIs) and benzodiazepines, which can help manage symptoms and reduce anxiety levels.

  • Psychodynamic therapy: This therapeutic modality seeks to explore underlying emotional and psychological issues contributing to anxiety symptoms, often delving into past experiences and subconscious conflicts.

  • Biological perspective: This approach examines the genetic factors and neurological circuits associated with anxiety disorders, presenting a biological foundation for understanding and treating these conditions.

Developmental Psychopathology Perspective

This perspective emphasizes the interplay of biological, cognitive-behavioral, and emotional factors over the lifespan, suggesting that understanding anxiety disorders necessitates considering both early development and environmental influences in shaping anxiety responses throughout life.